Malperfusion in Patients With Acute Type A Aortic Dissection: A Nationwide Analysis
- PMID: 39848556
- DOI: 10.1016/j.athoracsur.2025.01.002
Malperfusion in Patients With Acute Type A Aortic Dissection: A Nationwide Analysis
Abstract
Background: This study describes in detail the clinical burden of malperfusion associated with acute type A aortic dissection (ATAAD) in a large, national cohort and the effect of treatment strategy on outcomes.
Methods: All patients undergoing repair of ATAAD between 2017 and 2020 in The Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database were studied. Malperfusion was defined using STS definitions on the basis of imaging or the surgeon's evaluation. Multivariable logistic regression was used to analyze the effect of patient and treatment factors on outcomes in patients with and without malperfusion.
Results: A total of 9958 patients undergoing ATAAD repair were studied. Preoperative malperfusion occurred in 27.7% (2748 of 9958) of cases and most often involved the extremity (14.9%; 1484 of 9958), renal (10.2%), or cerebral (9.8%) vascular beds. Operative mortality was much greater among patients with malperfusion (26.8% vs 13.6%; P < .001). After adjustment, coronary malperfusion was associated with the highest odds of mortality (odds ratio, 2.28; 95% CI, 1.85-2.81; P < .001) followed by mesenteric malperfusion (odds ratio, 1.82; 95% CI, 1.45-2.28; P < .001). Cerebral malperfusion was not independently associated with significantly increased odds of mortality (odds ratio, 1.14; 95% CI, 0.94-1.38; P = .18). Partial arch replacement (zone 1 or zone 2) compared with ascending aorta or hemiarch replacement only showed a similar rate of mortality in patients with malperfusion (24.8% vs 26.9%; P = .99) and without malperfusion (11.6% vs 13.6%; P = .54).
Conclusions: Preoperative malperfusion in ATAAD was common and associated with significant operative mortality, which varied according to the malperfused region. Partial aortic arch replacement, compared with ascending aorta or hemiarch replacement alone, was not associated with increased mortality.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosures Hiroo Takayama reports a relationship with May and Samuel Rudin Family Foundation that includes: funding grants. Joseph Bavaria reports a relationship with W.L. Gore & Associates that includes: consulting or advisory; and with Terumo Aortic that includes: consulting or advisory. Anthony L. Estrera reports a relationship with Artivion that includes: board membership; and with W.L. Gore & Associates that includes: consulting or advisory. Hiroo Takayama reports a relationship with Artivion that includes: consulting or advisory. Eric E. Roselli reports a relationship with Artivion that includes: consulting or advisory; with Cook Medical that includes: consulting or advisory; with Edwards Lifesciences that includes: consulting or advisory; with W.L. Gore and Associates that includes: consulting or advisory; with Medtronic that includes: consulting or advisory; and with Bolton Medical España that includes: consulting or advisory. Himanshu J. Patel reports a relationship with Endospan that includes: consulting or advisory. Himanshu Patel reports a relationship with W.L. Gore and Associates that includes: consulting or advisory; and with Medtronic that includes: consulting or advisory. Michael E. Bowdish serves as Chair of the Society of Thoracic Surgeons Adult Cardiac Surgery Database Task Force and Senior Editor of The Annals of Thoracic Surgery. Bradley G. Leshnower reports a relationship with Endospan that includes: consulting or advisory; and with Medtronic that includes: speaking and lecture fees. Nimesh D. Desai reports a relationship with W.L. Gore & Associates that includes: consulting or advisory; and with Terumo Aortic that includes: consulting or advisory.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources